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DISRUPTION OF DNA POLYMERASE ζ PROMOTES AN INNATE IMMUNE RESPONSE

Sara K. Martin, B.A.

Advisory Professor: Richard. D. Wood, Ph.D

DNA polymerase ζ (pol ζ) is a specialized polymerase that protects cells from the
consequences of DNA damage and stress. Without pol ζ function mammalian cells and
yeast are exquisitely sensitive to genotoxic stresses including ultraviolet irradiation and
platinum compounds such as the chemotherapeutic agent cisplatin. This elevated sensitivity
arises from the central role of pol ζ in lesion bypass. Pol ζ is also required to protect cells
from endogenous genomic damage or stress. In primary mammalian cells, the function of
pol ζ is required for genome protection and normal proliferation. Immortalized Rev3l
knockout (KO) MEFs are under considerable constitutive genomic stress, as demonstrated
by elevated levels of micronuclei formation. As the cellular consequences of this stress
remain unexplored, genome-wide transcriptional changes were measured in Rev3l KO
MEFs. The work in this thesis demonstrates that loss of pol ζ promotes activation of an
innate immune response.
Rev3l knockout MEFs had over 1000 genes that were either upregulated or
downregulated more than 4-fold. Importantly, this revealed that loss of Rev3l induced an
increase in expression of known interferon-stimulated genes indicating that the innate
immune system may be activated. Increased expression of selected interferon-stimulated
genes was confirmed at the mRNA and protein levels in Rev3l KO MEFs.
Recently DNA damage has been shown to activate the innate immune system as
another level of the DNA damage response. Micronuclei and other forms of cytosolic DNA,
iv

that can arise from genomic stress, can activate the cytosolic DNA sensor cGAS which
promotes an interferon response with its signaling partner, STING. Knockdown of cGAS and
STING in Rev3l KO MEFs significantly reduced expression of interferon-stimulated genes
indicating that loss of pol ζ promotes activation of the cGAS-STING pathway. In sum the
work in this thesis demonstrates that cells with defective pol ζ are under a constitutive
activation of the cGAS-STING pathway. Pol ζ is already being explored as a therapeutic
target to sensitize tumors to chemotherapeutic agents, like cisplatin. This work suggests that
targeting pol ζ may also engage the innate immune system which could widen the uses of
targeting pol ζ in cancer treatment.
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CHAPTER 1
DNA polymerase ζ protects genome integrity

This chapter has been adapted from: DNA polymerase ζ in DNA replication and repair by
Sara K. Martin and Richard D. Wood in Nucleic Acids Research reproduced by permission
of Oxford University Press (https://doi.org/10.1093/nar/gkz705).

1.1 DNA polymerase ζ (pol ζ) structure, composition and biochemistry
Mammalian genomes encode 16 known DNA polymerases. This vast tool kit includes
specialized DNA polymerases that carry out genome maintenance and repair outside of
typical DNA replication. The subject of this thesis is the function of DNA polymerase, pol ζ,
which is universally present in eukaryotes including fungi, plants, and animals. Genetic
studies of budding yeast Saccharomyces cerevisiae have long established that pol ζ is a
biologically fundamental enzyme. Yeast require pol ζ to tolerate genomic assaults, by
facilitating translesion synthesis past lesions but at the price of promoting damage-induced
mutagenesis. In addition to pol ζ’s role in handling genotoxin-induced damage, pol ζ also
has a poorly understood role in protecting the genome in normal replicating cells. In
mammals, this function of pol ζ is integral to genome integrity and survival.
Pol ζ is a multiple-subunit enzyme. The catalytic subunit is called Rev3p in budding
yeast Saccharomyces cerevisiae, and has 1504 amino acid residues. In mammalian cells,
the orthologous protein REV3L is twice the size (3130 amino acids in human cells).
Although the mammalian and yeast enzymes have some basic biochemical similarities,
there are also significant functional differences, as summarized below.
Rev3p/REV3L is a member of the “B-family” of DNA polymerases. The other B-family
DNA polymerases in eukaryotes (Pols α, δ, and ϵ, Fig 1A) are components of the core DNA
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replication apparatus. The C-terminal portion of Rev3p/REV3L encompasses most of the
conserved DNA polymerase domain (Fig 1B, C).
A conserved N-terminal domain forms part of the overall polymerase fold [1, 2] (Fig
1D). Structures of the homologous regions of other B-family DNA polymerases show that the
N-terminal domain caps the exonuclease domain, and contains residues that make direct
contacts to DNA [2-5]. In the other B-family polymerases, the DNA sequence encoding the
N-terminal domain is directly adjacent to that encoding the exonuclease domain (Fig 1A).
However, for Rev3p/REV3L and its orthologs, a large insertion separates the N-terminal
domain from an inactive exonuclease domain (Fig 1B, 1C). In yeast, pol δ, a ~45 amino acid
region immediately downstream of the exonuclease domain (Fig 1A, light green) also folds
with the N-terminal domain [3]. This region is conserved and structural modeling predicts
that it folds similarly with the N-terminal domain in Rev3p (Fig 1B-D). A recent cryo-EM
structure indeed shows the N-terminal domain forming part of the catalytic module [6].
A single exon encodes the large central insertion that interrupts the domains of the
catalytic core, and its variation across species results in large differences in the protein size.
In mammalian REV3L genes, this exon is relatively gargantuan (encoding 1386 amino acids
in humans), resulting in a protein double the size of yeast Rev3p [7] (Fig 1A). While this
single exon insert contains many stretches of predicted disorder, it is also home to a
conserved positively charged domain that is necessary for efficient polymerase activity of
the recombinant protein [8]. A ~250 amino acid region of the large insert of REV3L is highly
homologous to the NEXMIF (KIAA2022) gene [7]. This is annotated as Pfam domain
DUF4683. Mutations in the NEXMIF gene have been associated with autism spectrum
disorder [9]. A recent analysis of Nexmif knockout mice revealed neuronal defects and
impaired function in the synapse of neurons [10]. However, the function of the NEXMIF gene
and the role this domain plays in REV3L remains unknown. Whether this uniquely large
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insert between the N-terminal domain and that of the B-family polymerase domain in REV3L
contributes to pol ζ function is an intriguing unexplored question.
Like the other B-family polymerases, pol ζ contains multiple accessory subunits,
including two subunits that are shared with pol δ: Pol31p/POLD2 and Pol32p/POLD3. The
C-terminal domain of Rev3p/REV3L directly binds Pol31p/POLD2 [8, 11-13] (Fig 1E-F). The
C-terminal domain contains two cysteine clusters: one that binds zinc (CysA) and one that
binds an iron-sulfur [4Fe-4S] cluster (CysB) [11] (Fig 1A-C). CysB is essential for the
binding of Pol31p/POLD2 to Rev3p/REV3L and pol ζ function [8, 12, 13]. Pol32p/POLD3
binds indirectly through its interaction with Pol31p/POLD2. Pol ζ includes a third accessory
subunit, Rev7p/REV7 (mammalian gene name MAD2L2) [14].
In mammalian REV3L there are two adjacent binding domains for REV7 with a
consensus ϕϕxPxxxxPSR (where ϕ represents an aliphatic amino acid residue) [15, 16].
One of these mammalian binding sites resides in the large exon (Fig 1C). Crystal structures
of REV7 bound to the two corresponding REV3L peptides have been obtained [17, 18].
Dimerization of REV7 appears to contribute to pol ζ biological function in mammalian cells
[18, 19]. Similar to the mammalian complex, yeast Rev7p binds as a dimer in pol ζ, although
this interaction is mediated by a different sequence consensus, containing two consecutive
prolines in each Rev7p binding site (Fig 1B) [2]. Rev7p greatly enhances pol ζ activity in
vitro through an unknown mechanism [20]. Similarly, Pol31p/POLD2 and Pol32p/POLD3
stimulate the activity of Rev3p/REV3L-Rev7p/REV7 [8, 13].
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Figure 1. Rev3p/REV3L is a B-family DNA polymerase. Schematic of the catalytic subunits of A)
pol δ (Pol3p), B) yeast pol ζ (Rev3p) and C) human pol ζ (REV3L). All contain a conserved N-terminal
domain (NTD, dark and light green), an exonuclease domain (EXO, blue), a B-family polymerase
domain (POL, red), and a C-terminal domain (CTD, orange) with two metal binding sites: one that
binds zinc (CysA) and one that binds an iron-sulfur cluster (4Fe-4S, CysB). The NTD is annotated by
Interpro as domain IPR006133. The EXO domain is active in pol δ but inactive in pol ζ (EXO-). Rev7p
binding occurs at two binding sites in the insertion in between the NTD and the EXO- in Rev3p. In
human REV3L, exon 14 encodes a large insertion that contains a positively charged domain (PCD,
purple) of unknown function. Two REV7 binding sites [16] are well-conserved in mammals. D) We
generated a predicted model of Rev3p using PHYRE2 [21], with the known structure of Pol3p [3] as a
template (PDB: 3IAY) given that Rev3p shares the highest sequence identity with pol δ. This shows
the predicted folding of the NTD with the catalytic core of REV3L. E) Schematic of pol ζ from the
budding yeast Saccharomyces cerevisiae. The catalytic subunit Rev3p binds to the accessory subunit
Rev7p. Pol δ accessory subunits, Pol31p-Pol32p, bind to the C-terminal domain (CTD). Pol31p interaction is coordinated by the iron-sulfur cluster (4Fe-4S) in Rev3p. Rev7p and Pol32p interact directly.
Rev7p and Pol32p mediate the interaction with Rev1p. F) Schematic of human pol ζ. A dimer of
REV7 can bind to the catalytic subunit, REV3L. POLD2 binds REV3L at the CTD, coordinated by the
iron-sulfur (4Fe-4S) cluster. POLD3 binds to POLD2. It is unknown whether REV7 and POLD3
directly interact as Rev7p and Pol32p do in yeast. REV1 can bind human pol ζ through interactions
with REV7 and POLD3.
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A low resolution structure (23 Å) of yeast pol ζ obtained by negative stain electron
microscopy suggested that all three regulator subunits form a hub, with Rev7p making direct
contact to Pol32p [2] (Fig 1E). A higher resolution structure shows the two Rev7p subunits;
revealing that one Rev7p subunit has interfaces with both Pol31p and Pol32p [6]. The
function of this hub in pol ζ remains largely unexplored. One important role is that it may
serve to regulate recruitment of Rev1p/REV1, a major regulator of translesion DNA
synthesis (TLS) (Fig 1E-F). As will be discussed later, proper pol ζ function requires interaction with Rev1p/REV1. Rev1p/REV1 binds to pol ζ through direct interactions with both
Rev7p/REV7 and Pol32p/POLD3 [15, 22-27].
Pol ζ is the only specialized DNA polymerase in eukaryotes that is a member of the
B-family; the other specialized DNA polymerases belong to the A, Y, X, and AEP families.
The error rate of pol ζ is intermediate between replication and other translesion synthesis
DNA polymerases. It is 10 to 100-fold less accurate than its fellow B-family members in the
DNA replication apparatus, but 5 to 30-fold more accurate than Y family translesion DNA
polymerases [28]. However, much of this analysis was conducted using Rev3p and Rev3pRev7p, before pol ζ was discovered to include Pol31p and Pol32p.
1.2 Pol ζ as a major extender enzyme past DNA lesions
Damage removal is usually the first line of defense against UV radiation or chemical adducts
in DNA. For example, base excision repair (BER) removes abasic sites, and nucleotide
excision repair removes UV radiation-induced pyrimidine dimers. If lesions are not removed
by the time of DNA replication, they can block replication fork progression. In order for
replication to reach completion the lesion must be bypassed. When replicative DNA
polymerases stall at a lesion, there are two well-characterized routes of lesion bypass (Fig
2). In template switching, the lesion is circumvented completely by synthesis using the undamaged sister strand. In TLS the lesion is directly bypassed by specialized DNA polymerases.
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The route to either template switching or TLS is directed by posttranslational
modifications to proliferating cell nuclear antigen (Pol30p/PCNA) [29-31]. The homotrimeric
Pol30p/PCNA forms a sliding clamp around the DNA, serving as an anchor for DNA polymerases. When a replication fork stalls at a lesion, Pol30p/PCNA becomes monoubiquitinated at K164 and promotes TLS. Alternatively, Pol30p can be polyubiquitinated at K164
(in yeast, by Mms2p/Ubc13p/Rad5p complex), and this shunts bypass to the template
switching pathway.
TLS DNA polymerases and replicative DNA polymerases have contrasting
biochemical properties that serve their respective functions. The high fidelity of replicative
DNA polymerases is boosted by a functional 3´-5´ editing exonuclease domain that corrects
most errors. In contrast, TLS polymerases generally have low fidelity and lack a functional
exonuclease domain. In Y-family DNA polymerases, this low fidelity has been attributed to a
more spacious active site, which allows TLS DNA polymerases to incorporate bases across
from lesions that cannot be accommodated by the active sites of replication polymerases
[32]. Another distinction between TLS polymerases and replicative polymerases is
processivity, the amount of DNA synthesized in a single event before dissociation. TLS
polymerases are less processive than replication polymerases. For example, the Y-family
TLS DNA polymerase, pol η, even when stimulated by the physiologically relevant
monoubiquitinated PCNA, has dramatically lower processivity than pol δ [33]. Low
processivity may be selectively advantageous for organisms, preventing error prone
polymerases from uninterrupted synthesis of large swaths of DNA which could leave
genomes riddled with errors. Given the introduction of errors that occur with TLS, it makes
sense that this is a tightly regulated process.
A large part of this regulation centers on monoubiquitinated Pol30p/PCNA, which
serves as a docking site for key TLS players. For instance, the master TLS regulator
Rev1p/REV1, binds monoubiquitinated Pol30p/PCNA facilitated by interactions through its
BRCT, PAD, and UBM domains [34, 35]. Rev1p/REV1 interacts with pol ζ via Rev7p/REV7
6

and Pol32p/POLD3 as described earlier [15, 22-27]. Rev1p/REV1 also interacts with Yfamily TLS polymerases [36-38]. This structural function of Rev1p/REV1, mediating key
protein-protein interactions, is widely appreciated as essential to functional TLS [29-31, 39,
40]. As discussed later, in certain scenarios Rev1p also contributes to TLS through its
catalytic activity as a deoxycytidyl transferase [41].
Two models have been proposed for the timing of TLS: it may occur at the replication
fork or after replication has continued through repriming past the lesion (Fig 2). These
models are not mutually exclusive, and there is indirect evidence for both outcomes [42]. In
both scenarios, monoubiquitination of Pol30p/PCNA instigates TLS, followed by association
of Rev1p/REV1 and recruitment of a TLS polymerase.
Pol ζ has been implicated in direct bypass of several types of lesions as thoroughly
reviewed previously [43]. Correspondingly, cells with defective pol ζ are sensitive to an array
of DNA damaging agents such as UV radiation, cisplatin, and aflatoxin, which result in
distorting or “bulky” adducts on DNA [16, 44, 45]. However, depletion of Rev3l in human
cells does not alter survival or mutagenesis after BPDE treatment, another chemical that
induces bulky adducts [46]. Intriguingly, REV1, REV3 and REV7 were recruited to sites of
DNA-protein crosslinks, implying that pol ζ may serve some function at these lesions [47].
Additionally, pol ζ has been linked to interstrand crosslink repair [48, 49], although
biochemically Y-family polymerases appear to be intrinsically more efficient at bypassing
interstrand links than pol ζ [50]. However, in the context of Rev1p this could change as
discussed below. Thus, pol ζ function at interstrand crosslinks is still an active area of
research.
On synthetic templates, Pol ζ can mediate insertion opposite some DNA adducts, as
well as subsequent extension. Sometimes lesion bypass may be coordinated by two
specialized polymerases. Pol ζ may play a role during lesion bypass by extending the
primer-terminus after a nucleotide has been incorporated opposite a lesion by another TLS
polymerase [51]. For example, pol η and pol ζ have complementary biochemical activities
7

that imply they are cooperating partners for lesion bypass. In vitro, pol η efficiently inserts a
nucleotide opposite a 1,2 (dGpG) cisplatin intrastrand crosslink, while pol ζ cannot [8]. In
contrast, pol η starts to falter in extension past a lesion site, while pol ζ can efficiently extend
past the lesion [8].
However, a recent study suggested that pol η can produce products that inhibit pol ζ
extension, by acting to directly extend the unhooked crosslink strand [52]. Intriguingly,
biochemical investigation of the complete pol ζ complex in the presence of PCNA showed
that Rev1p allowed pol ζ to function as an initial inserter enzyme while Rev1p was
dispensable for extension past an unhooked nitrogen mustard-based interstrand crosslink
[52]. This recent study suggests that one of the catalytic-independent functions of Rev1p
could be to enable pol ζ to carry out the full process of translesion bypass of interstrand
crosslinks [52]. This raises the interesting question of whether this pol ζ-Rev1p function
could act at the insertion step in the bypass of other DNA lesions.
This introduces several important mechanistic questions. Does pol ζ continue
significant synthesis after extending from a lesion? If the lesion is bypassed during DNA
replication, when does pol ζ hand the reins back to the higher fidelity replicative
polymerases? If lesion bypass occurs in a gap left after replication, can pol ζ fill the gap on
its own?
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Figure 2: Models for lesion bypass. A) When a replication fork stalls at a lesion, PCNA becomes
monoubiquitinated by Rad6p/Rad18p at K164. This is the initial step in both lesion bypass pathways,
translesion synthesis (TLS) and template-switching. For both pathways, models have been proposed
for bypass occurring at the replication fork (co-replication) or after synthesis has reprimed
downstream of the lesion (post-replication). Here, bypass is depicted on the leading strand. B-C)
Template switching is instigated by polyubiquitination of K164, by Mms2p/Ubc13p/Rad5p. This
pathway involves switching to the undamaged sister strand as a template for synthesis. This pathway
may occur at the fork – one mechanism would be fork reversal as depicted here – or template
switching may occur after the replication fork has moved on. D-E) Rev1p binds monoubiquitinated
Pol30p/PCNA (Ub-PCNA) facilitated by interactions through its BRCT, PAD, and UBM domains. A
TLS pol such as pol η is recruited through interactions with Rev1 and Ub-PCNA. After recruitment, pol
η (or another TLS pol) can insert a nucleotide opposite the lesion. Next pol ζ is recruited to Ub-PCNA
by its interaction with Rev1p, and continues extension past the site of the lesion. In a co-replication
model pol ζ would hand synthesis off to a replication polymerase. In the post-replication or “gap filling”
model, pol ζ may fill in a gap either on its own or might hand off to replication polymerases to finish
synthesis in the gap.
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1.3 Pol ζ synthesis is associated with DNA replication stress
In yeast, pol ζ is responsible for a substantial portion (half or more) of “spontaneous”
mutations in cells that are not challenged with external DNA damaging agents [53-55]. This
implies that cells use pol ζ to copy DNA containing endogenous lesions (such as AP sites)
and in response to other stresses. One way DNA replication stress can be induced is
through depletion of dNTP pools by incubation with hydroxyurea (HU). Such exposure to HU
induces point mutations in yeast, which are largely dependent on REV3 [56]. Additionally,
DNA synthesis by pol ζ is not dramatically altered by changes in dNTP levels in vitro or in
vivo, unlike other DNA polymerases [57]. Together such data are consistent with a model
whereby pol ζ synthesis plays a role in dealing with replication stress, including
circumstances where dNTP levels are low enough to hinder chromosomal replication.
However, there are multiple pathways for cells to deal with nucleotide depletion since
deletion of REV3 in yeast does not confer enhanced sensitivity to HU [58]. Interestingly,
knockdown of ribonucleotide reductase M1 (which should result in lower dNTP pools)
decreased the viability of REV3L-defective human cells more than REV3L-proficient controls
[59]. More research may help clarify the roles mammalian pol ζ may play when cells are
under replication stress.
Pol ζ-dependent mutagenesis in yeast also occurs following other types of replication
stress. Mutations in replicative polymerases can cripple the replisome and result in elevated
mutagenesis. This has been called defective-replisome-induced-mutagenesis (DRIM).
Importantly, the vast majority of this mutagenesis is dependent on REV3 [56, 60].
Furthermore, the ability of Rev3p to interact with Pol31p-Pol32p is essential for DRIM
implying that pol ζ functions as a four-subunit complex in DRIM [61]. Additionally, REV3dependent mutations in DRIM increase when the template switching pathway is inhibited by
deletion of MMS2. This illustrates the importance of PCNA directing repair choice to either
pol ζ synthesis or the “error-free” template switching when the replisome runs into trouble.
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Together this work demonstrates that there are multiple routes for cells to overcome various
sources of replication stress, and that pol ζ synthesis is an important but mutagenic route.
A further source of replication stress arises when the replisome encounters DNA
sequences that are challenging to replicate, such as sequences forming secondary
structures [62, 63] (Fig 3A). Spontaneous and DRIM pol ζ -dependent mutations often occur
at predicted sites of hairpin formation in vivo [64]. These same hairpin structures stall pol δ
in vitro. This highlights that introduction of REV3-dependent mutations can be sequencespecific, and could explain the variability in the REV3-dependent mutation rate when
different regions are monitored. DRIM is also dependent on the deoxycytidyl transferase
Rev1p. Mutations in response to replication perturbations were reduced in a REV1-deletion
strain as well as in a strain with a deletion in the REV1 BRCT domain mediating proteinprotein interactions. This is consistent with Rev1p having both a structural and enzymatic
function in bypass of DNA structures that are difficult to replicate [64].

1.4 Bypass of incorporated ribonucleotides by pol ζ
Another major source of replication stress arises from ribonucleotides (rNMPs) erroneously
incorporated into the genome during replication [65]. Multiple pathways exist to repair and
bypass rNMPs, which likely represent the most common error made during replication [6670]. One study has suggested that pol ζ-dependent bypass may be one of these pathways.
Most incorporated ribonucleotides are removed from DNA by ribonucleotide excision
repair. This process is initiated by RNase H2 (and perhaps RNase H1). An alternative repair
mechanism exists that is dependent on topoisomerase I [71, 72]. However, if unrepaired
rNMPs are present during replication they may be bypassed. Incorporated ribonucleotides
can also be bypassed by the MMS2-dependent template switching pathway discussed
above. Yeast cells lacking RNase H1, RNase H2 and Mms2p are only mildly sensitive to
HU, but co-deletion of pol ζ components in these cells dramatically sensitizes them to HU
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[73]. This suggests that pol ζ provides one mechanism for cells to survive replication fork
stalling induced by collision with rNMPs (Fig 3B).
Providing biochemical support for this model, two-subunit pol ζ (Rev3p-Rev7p) is
dramatically more efficient than pol δ at bypassing four tandem rNMPs [73]. It will be
intriguing to see if the four-subunit pol ζ (Rev3p-Rev7p-Pol31p-Pol32p) can bypass rNMPs
even more efficiently than Rev3p-Rev7p alone. In addition, it will be important to determine if
this function is conserved for mammalian pol ζ.
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Figure 3: Models for REV3-dependent synthesis at difficult-to-replicate regions in the genome.
A) Model, after Northam et al., for the role of pol ζ and Rev1p synthesizing non-B DNA [64]. Hairpin
structures in DNA can stall replicative polymerases. Ubiquitinated PCNA then recruits Rev1p. Rev1p
first acts enzymatically and inserts a dCTP near the base of the hairpin, after which it serves to recruit
pol ζ. Pol ζ then initiates synthesis on the opposing strand followed by repriming near the original site
of the hairpin, copying from this mismatched sequence. Alternatively, hairpin structures can be
bypassed by template switching. B) Model for pol ζ bypass of incorporated ribonucleotides proposed
by Lazzaro et al. [73]. Incorporated ribonucleotides can be repaired by ribonucleotide excision repair
or a Top1-dependent pathway. When incorporated ribonucleotides remain in the DNA during replication they have the potential to stall a replication fork. In yeast, pol ζ may bypass incorporated
ribonucleotides. C) Model for pol ζ replicating interstitial telomeric sequences (ITS), after Moore et al.
[74]. Telomeric proteins, at (ITS), may result in stalling of the replication fork. REV3 is proposed to fill
a gap caused by cleavage of the fork by the MRX endonuclease complex (Mre11p/Rad50p/Xrs2p)
followed by end resection. Alternatively, cells can deal with ITS through homology dependent repair
mechanisms (dependent on RAD51 or RAD52).
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1.5 Pol ζ and repetitive DNA sequences
Highly repetitive sequences are another impediment to replicative polymerases. An
important example are telomere sequence repeats that are found embedded in
chromosomes outside of the telomeres, called interstitial telomeric sequences (ITS). When
an ITS was placed within an intron of URA3, an increased rate of point mutations and
terminal sequence inversions was observed in adjacent gene segments [74]. The point
mutation rate was reduced 10-fold in a rev3 deletion strain [74]. These REV3-dependent
mutations appeared not to result from a repair of a double strand break, since the mutations
were not accompanied by indels in the ITS. The mutations were also dependent on Mre11p,
a component of a nuclease that acts on stalled replication forks and facilitate their
degradation. This led to the model that MRE11-dependent gaps are formed at ITS
sequences and are then filled in by pol ζ (Fig 3C). Mutations adjacent to the ITS increased
upon disabling homology-based repair by deletion of RAD51 or RAD52, but not after
disabling the template switching pathway by deletion of MMS2. This suggested that
homology-based repair pathways are an alternative repair mechanism at ITS sequences,
while canonical template switching is not.
REV3-dependent mutations in the neighborhood of other types of repetitive
sequences have been observed. Mutations in a URA3 reporter gene were observed as far
as 8 kb past an Alu inverted sequence quasi-palindrome; these mutations were largely
REV3-dependent [75]. Mutations also occur in the neighborhood of trinucleotide repeats [76,
77]. REV3-dependence of mutations in the chromosome adjacent to trinucleotide repeats
was most apparent in strains with replisomes carrying crippling pol3 or pol2 variants [75, 78].
While it was demonstrated that double strand breaks do form at these repeats, it is not
known whether the pol ζ-dependent mutations are dependent on the formation of a break.
It has been known for two decades that REV3-dependent mutagenesis occurs in
reporter genes located in the neighborhood of a double strand break induced by the HO
endonuclease [79, 80]. Nevertheless, REV3 is not essential for the repair of the break,
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leaving the question of the function of pol ζ synthesis around double strand breaks [79, 81].
Pol ζ is necessary for a specific type of single-ended DNA double strand break processing,
termed microhomology-mediated break induced replication (MMBIR, Fig 4) [82]. Singleended double strand breaks can arise from collapsed replication forks or degradation of
telomeres. Cells can repair the break through extensive synthesis, involving pol δ, called
break-induced replication (BIR, Fig 4). BIR uses the homolog as a template and a primer
with a substantial stretch of homology. In yeast BIR has been monitored by the induction of
a single ended break at the end of a single chromosome III by HO endonuclease, and
tracked with auxotrophic reporters. Deletion of the PIF1 helicase gene disables extensive
synthesis, resulting in collapse of BIR and the appearance of complex mutations near the
site of strand invasion [82]. These complex mutations can be explained by synthesis arising
from alternative templating at microhomologies. These mutations, in pif1∆ yeast, are thought
to arise from MMBIR, and such mutations were absent in strains with deletion of REV3 [82].
Point mutations downstream of the single-ended break repaired by MMBIR have not been
measured. Such experiments could provide insight into the extent of pol ζ synthesis and its
potential function during MMBIR.
An intriguing parallel arises from recent work in human cells, where restart of stalled
replication forks in BRCA2-deficient cells was dependent on the MUS81 endonuclease and
POLD3 [83]. A model proposed from this work was that reversed forks (Fig 2B) were being
cleaved by MUS81, forming a single-ended DNA break that was repaired with POLD3dependent synthesis. Whether this repair is mediated by pol δ, pol ζ, or combination of the
two remains unresolved.
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Figure 4: Model for the role of pol ζ in microhomology-mediated break-induced replication. In
break-induced replication (BIR) a single-ended DNA break is repaired by extensive synthesis on the
sister by pol δ. If the replication fork in BIR collapses, an alternative repair pathway called
microhomology-mediated BIR (MMBIR) can be used. A proposed model for MMBIR involves looping
of a strand, annealing to itself at a short region of homology (microhomology, MH), with pol ζ carrying
out DNA synthesis from this MH-paired primer. The extended strand re-associates with the sister
strand, annealing at a microhomology created during synthesis, and continues synthesizes using the
sister template. This model was proposed by Sakofsky et al. [82].
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1.6 Rev3l is an essential gene in mammalian primary cells
Yeast genetics resulted in the discovery of REV3 over four decades ago, and yeast studies
are still at the forefront of unravelling the multifaceted functions of pol ζ as a specialized
DNA polymerase. Disruption of REV3 does not decrease the viability of yeast. Despite its
known functions in genome maintenance, the loss of pol ζ function does not lead to the
formation of chromosomal rearrangements in yeast [84]. In contrast, in mammals, pol ζ
disruption instigates accumulation of genomic abnormalities and prevents normal cell
proliferation [85, 86]. Germline disruption of Rev3l results in embryonic lethality in mice [8789]. The indispensable nature of pol ζ likely stems from inadequately understood genome
protective functions. Disruption of Rev3l in B cells or keratinocytes in mice leads to acute
genomic stress in the target tissues [90-94]. Primary mouse embryonic fibroblasts (MEFs)
rapidly accumulate chromosome breaks at the first metaphase following Rev3l disruption
[86]. Loss of pol ζ in primary MEFs cripples cell proliferation, with the cells failing to replicate
past roughly two rounds of cell division following Rev3l disruption [86].
One question is whether the essential functions of REV3L depend directly on the
DNA polymerase, or whether only the structural presence of REV3L is needed. A
catalytically deficient REV3L might still interact with its protein partners and other DNA substrates, allowing viability of cells and mice. To determine whether ablation of the catalytic
activity of pol ζ is responsible for the severe consequences due to pol ζ disruption, mice
were engineered with specific inactivation of the catalytic activity. Conserved active site
aspartate residues necessary for activity (D2773, D2775) were changed to alanine, in two
independent studies. In both cases, no viable homozygous mice were produced, and the
corresponding embryos died early in embryogenesis [7, 95]. To investigate cell-autonomous
consequences of the specific polymerase alteration, primary MEFs were derived that carried
one null Rev3l allele, and one active site mutant allele [7]. The growth defects, DNA break
formation and cisplatin sensitivity of these cells were similar to cells harboring two null
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alleles [86]. These results showed that the DNA polymerase activity of REV3L is essential
for the genome protective functions.
The dramatic growth suppression in Rev3l knockout MEFs appears to be
ameliorated by blunting DNA damage quality control responses, for example by p53 deletion
[85] or T-antigen expression [86] (which inhibits p53 and other targets). However, p53
deletion utterly fails to rescue embryonic lethality of Rev3l disruption in mice [85, 96, 97].
This implies that there are additional, p53-independent, growth suppressive responses to
the genomic strain caused by Rev3l disruption.

1.7 Pol ζ as a tumor suppressor
If a cell can survive Rev3l disruption, this promotes oncogenesis. One consequence of the
genome protective function of pol ζ is that Rev3l is a suppressor of spontaneous tumor
formation. There are several examples. In Tp53-defective mice, a mosaic deletion of Rev3l
in the lymphocyte lineage caused an increased incidence and reduced latency of
lymphomas [90]. Conditional partial disruption of Rev3l in the mammary gland enhances the
incidence of mammary gland tumorigenesis [90]. About 90% of mice with disruption of Rev3l
in keratin-5 expressing cells acquired squamous cell carcinomas after one year [94]. It is
likely that the increased frequency of tumors is due to oncogenic chromosome
rearrangements in Rev3l-defective tissues. For example, cancers arising from Tp53defective and BRCA1 defective mouse epithelia are driven by amplifications or
translocations that result in elevated oncoprotein expression or oncoprotein-containing
fusions [98].

1.8 Inhibition of pol ζ as a potential therapeutic target
Genomic instability fuels cancer development and also provides a reservoir of genomic
variations that facilitate resistance to therapies. Tumor cells often have altered DNA repair
pathways, resulting in genomic instability, one of the defining hallmarks of cancer [99].
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However, this can lead tumor cells to rely more heavily on remaining intact repair pathways
to prevent genomic damage from reaching levels that lead to unescapable cell death. As a
result, targeted therapies have emerged that exploit specific DNA repair deficiencies in
tumor cells, the most prominent being the rise of PARP inhibitors in the clinic [100].
A potentially exciting prospect for cancer therapy is to inhibit the function of TLS in
tumor cells to block a remaining route of survival of cancer cells challenged with DNA
damaging chemotherapeutics. Depleting pol ζ function should increase the sensitivity of a
tumor to some DNA damaging drugs. Concomitantly, reduction of the TLS function would be
expected to reduce drug-induced base substitution and frameshift mutagenesis. This could
advantageously reduce the pool of drug-induced mutated tumor cells, which could slow
down recurrence of a tumor.
This has been explored in mouse models. Depletion of Rev3l mRNA levels resulted
in tumor regression in multiple xenograft models [101-103]. Specific inhibitors of the catalytic
activity of Rev3l could also inhibit pol ζ function [7, 95]. A more recent approach may be to
target small-molecule inhibitors to the pol ζ complex [104]. One strategy is to inhibit specific
interactions between proteins in the extended pol ζ complex. Protein-protein interactions
between the C-terminal domain of Rev1 and the Rev1-interacting region of other TLS DNA
polymerases play an essential role in TLS. A fluorescence polarization-based assay was
used in a pilot screen for small molecule inhibitors of this protein-protein interaction [105].
Small molecule scaffolds that disrupt this interaction were identified. Survival and
mutagenesis assays in mammalian cells exposed to cisplatin or UV radiation indicated that
these compounds inhibit mutagenic Rev1 / pol ζ-dependent TLS in cells [105].
There are many other protein-protein interactions within the pol ζ complex [24] (Fig
1). Some of these interactions are candidates for small-molecule targeting. Recently an
inhibitor that prevents the REV7-REV1 interaction through promoting dimerization of REV1
was identified [106]. Importantly, when combined with cisplatin, this inhibitor reduced tumor
size and increased survival in a mouse xenograft model. An important caveat is that
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disruption of Rev3l function causes cells to be susceptible to increased chromosome
breaks, gaps, and oncogenic chromosome rearrangements (Fig 5). Crippling of REV1
function (in a nucleotide excision repair-defective background) enhances UV radiationinduced carcinogenesis by elevating inflammatory hyperplasia [107]. Therefore, pol ζ
inhibition could sometimes contribute to generating drug-resistant variants in recurrent
cancer, and such possibilities will have to be monitored carefully.
In conclusion, pol ζ is a specialized DNA polymerase that functions in canonical TLS
but also has broader roles in unchallenged replicating cells. Uncovering the roles pol ζ plays
in preserving genomic stability in mammalian cells could have broad reaching implications in
understanding carcinogenesis and in developing combination therapies for some cancers.
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Figure 5: Pol ζ operates as a tumor suppressor by preserving chromosomal stability at the
cost of point mutations in mammals. A) In cells with proficient pol ζ, endogenous and exogenous
sources of stress or damage require pol ζ synthesis to prevent gross chromosomal abnormalities, but
at the cost of introducing point mutations. B) Without pol ζ, cells may accrue fewer point mutations
but also acquire increased chromosomal abnormalities when challenged with exogenous or
endogenous sources of damage or stress. These chromosomal abnormalities lead to growth
suppression and cell death in cells with functional checkpoints. Cells without functional checkpoints
may be able to survive and the chromosomal abnormalities can drive oncogenesis.
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1.9 Rationale and Aims

As discussed in this chapter, deletion of the catalytic subunit of pol ζ, Rev3l, places cells
under constitutive genomic stress. The overarching goal of my thesis research was to
unravel the consequences of this genomic pressure due to Rev3l disruption. The first aim of
my thesis was to develop a complementation system to address phenotypes of Rev3l loss in
mouse embryonic fibroblasts (MEFs).
The second aim was to use this experimental set up to perform genome-wide mRNA
sequencing to determine the consequences of Rev3l disruption in MEFs. The results of the
second aim, discussed in Chapter 3, revealed that cells with disrupted Rev3l had elevated
expression of genes related to the innate immune system. While unexpected, these results
tie into our growing understanding of how DNA damage intersects with the innate immune
system.

1.10 DNA damage induces an innate immune response
The innate immune system consists of multiple pathways to protect organisms from
infections. First the immune system must be able to distinguish foreign material from self
and then it acts to stop viral or bacterial propagation [108]. There are multiple surveillance
proteins in the innate immune system that patrol cells for molecules associated with
pathogens. One type of these surveillance proteins are cytosolic nucleic acid receptors
[109]. These receptors bind foreign DNA and RNA in the cytosol and activate the innate
immune system.
While there are multiple nucleic acid sensors, a DNA sensor, cGAS, plays a
prominent role in response to viral and bacterial DNA [110, 111]. Activation of cGAS creates
a signaling cascade that induces an innate immune response. cGAS binds DNA in a
sequence-independent manner [110-112]. The binding of DNA promotes cGAS dimerization
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and triggers a conformational change that activates cGAS, which is a nucleotidyl transferase
[113]. Specifically, binding of DNA to cGAS results in the production of 2’3’ cyclic GMP-AMP
(cGAMP) from GTP and ATP [110, 111].
cGAMP binds the ER-bound receptor STING and causes conformational changes
that promote oligomerization, phosphorylation, and activation of the kinase, TBK1 [114-116].
Active TBK1 phosphorylates the C-terminal domain of STING which recruits the interferon
transcription factor, IRF3. TBK1 then also phosphorylates IRF3 which promotes IRF3
dimerization and localization to the nucleus where it promotes transcription of interferons
and other interferon-stimulated genes [117]. In the presence of an infection, interferons and
other interferon-stimulated genes promote inhibit viral or bacterial replication and recruit the
adaptive immune system [118]. In addition, interferon pathways can suppress cell growth
[119]. As a result, the cGAS-STING pathway is an important part of the innate immune
system that activates an interferon response due to the presence of foreign DNA.
As was mentioned above cGAS binds double stranded DNA in a sequenceindependent manner and endogenous DNA can also activate cGAS. Treatment with various
DNA damaging agents, including etoposide and ionizing radiation, can induce an interferon
response as reviewed in [120]. This has been attributed to forms of cytosolic DNA that
escape the nucleus after genomic DNA damage. For example, micronuclei accumulate after
treatment with ionizing radiation [121]. Micronuclei are chromosomes or fragments of
chromosomes that missegregate and form a discrete nuclear compartment in the cytosol. It
has been proposed that micronuclei provide a potential source of DNA to activate cGAS
[121], although this is controversial and will be discussed in more detail later. Micronuclei
aren’t the only proposed source of self-DNA for activation of cGAS. For example,
accumulation in the cytosol of ssDNA, in cells under replication stress, and mitochondrial
DNA, in cells under mitochondrial stress, also correlate with cGAS activation [122, 123].
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In addition to cells being treated with DNA damaging agents, loss of certain proteins
involved in DNA repair and replication stress cause activation of the cGAS-STING pathway
[121, 124-126]. These include: RNase H2, which is involved in ribonucleotide excision repair
(and R-loop processing), BLM, a multi-functional helicase with roles in homologous
recombination and stalled replication forks, and BRCA2, which has roles in both
homologous recombination and replication fork protection. Importantly these three proteins
all have three things in common, their loss in mice causes embryonic lethality and their loss
in cell lines results in the accumulation of micronuclei and activation of the cGAS-STING
pathway [121, 124-126].
The activation of cGAS in cells with dangerously fragmented genomes is
advantageous in the fact that it can hinder cell growth in these cells. For example, cellular
senescence is promoted by cGAS [127]. In this way the cGAS-STING pathway can act as
another checkpoint for DNA damage. However, hyperactivation of cGAS can be detrimental.
For example, mutations in RNase H2 cause an autoimmune disease in humans and
constitutive cGAS activation in patient cells [128]. Thus, the regulation of cGAS recognizing
self-DNA needs to be tightly regulated.
The localization of cGAS plays a role in limiting cGAS activation by self-DNA in the
cytosol [129]. The N-terminal domain of cGAS binds to phosphoinositides in the inner
plasma membrane. As a result, cGAS is concentrated along the plasma membrane placing
it in prime position to recognize foreign DNA entering the cell, but further away from selfDNA escaping the nucleus. In fact, disruption of the cGAS-phosphoinositide interactions
increases a cGAS-STING response due to DNA damage, but diminishes the response to
viral infection [129].
But cGAS localization is even more complex, because cGAS is also a nuclear
protein with a well validated NLS [130]. Its nuclear function has yet to be fully understood. A
recent structural study reveals that cGAS binds the nucleosome and makes direct
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interactions with histones [131]. When cGAS binds the nucleosome, this results in blocking
of multiple DNA binding sites and inhibiting dimerization of cGAS [131, 132]. Since both
DNA binding and dimerization are essential in converting cGAS into an active conformation,
this explains why nuclear chromatin-bound cGAS remains inactive [131, 132].
Micronuclei correlate with cGAS activation and cGAS is found to colocalize with a
fraction of micronuclei [121-123]. As a result, it has been suggested that micronuclei are a
prime source of DNA for cGAS activation. However, it is not clear whether cGAS is entering
through ruptured nuclear envelopes or if the micronuclei brought nuclear cGAS already
bound to its chromatin. If cGAS is bound to chromatin in micronuclei, it seems likely that this
pool of cGAS is inactive. However, this does not necessarily exclude micronuclei from being
a potential source of DNA for cGAS activation.
Micronuclei are under-replicated and experience intense genomic trauma, given that
that micronuclei can be the site of chromothripsis, where a chromosome is dramatically
shattered and repaired out of order [133]. All this DNA fragmentation could theoretically
disrupt chromatin and produce DNA that could activate cGAS.
One interesting but highly speculative question is: if micronuclei bring their own pool
of cGAS from the nucleus, could this lead to preferential recognition of fragmented DNA
within the micronucleus, since the majority of cGAS in the cytosol is sequestered near the
plasma membrane? Although micronuclei clearly correlate with cGAS activation, how and if
they activate cGAS is an exciting area of research.
Given that loss of Rev3l results in micronuclei formation and upregulation of immune
system related genes, this raises the possibility that disruption of Rev3l induces an innate
immune response. As a third aim I investigated whether loss of Rev3l resulted in expression
of interferon-stimulated genes and IRF3 phosphorylation, which would be consistent with an
innate immune response. For the final aim of my thesis, I interrogated whether the cGASSTING pathway promoted the innate immune response in cells lacking Rev3l.
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CHAPTER 2 – Results & Future Directions
Developing a model system to investigate consequences of disruption of pol ζ
Parts of this chapter are adapted from a manuscript uploaded to bioRχiv. “Deficiency in
Translesion DNA Polymerase ζ Induces an Innate Immune Response” by Sara K. Martin,
Junya Tomida, and Richard Wood. doi: https://doi.org/10.1101/2020.03.02.972513

2.1 A shortened REV3L construct rescues some phenotypes of pol ζ disruption
In order to dissect the consequences of the poorly resolved genome protection function of
pol ζ, we set up a complementation system using large T-antigen immortalized mouse
embryonic fibroblasts (MEFs) [86] either with a pol ζ proficient background, Rev3l
heterozygous (HET) background, or a pol ζ deficient background, Rev3l knockout (KO) (see
Materials and Methods).
The full-length human REV3L gene is large, over 10 kb, and pushes the capacity
limits for lentiviruses making cell lines difficult to establish that express the full-length
protein. So instead we stably expressed a biochemically active shortened human REV3L
construct, TR4-2 [8] (Fig 6A) with an N-terminal Flag-HA tag in Rev3l KO MEFs using
lentiviral infection (Fig 6B-C). The TR4-2 construct lacks regions that are poorly conserved
and are predicted to be disordered. TR4-2 maintains the key catalytic core of the
polymerase, the binding sites for pol ζ subunits POLD2, POLD3, and REV7, and a positively
charged domain which promotes polymerase activity [8] (Fig 6A). In addition, TR4-2
expresses at much higher levels than the full-length protein [8] which may be in part due to
the deletion of a protease (TASP1) cleavage site [134]. Therefore, we chose TR4-2 for its
ability to be readily expressed and easily manipulated experimentally.
In order to determine whether changes in phenotypes due to the expression of TR42 were tied specifically to the function of the pol ζ complex, mutations in the REV7 binding
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sites were introduced into TR4-2. The REV7 binding site mutant (4A), which changes four
key prolines in the binding site to alanine, was introduced into TR4-2 (Fig 6A). Similar to the
full-length REV3L construct [16] TR4-2-4A failed to bind REV7 (Fig 6D). Flag-HA tagged
TR4-2 and TR4-2-4A mutant were transiently expressed in HEK293T cells. REV7 coimmunoprecipitated when TR4-2 was immunoprecipitated with a Flag antibody but did not
co-immunoprecipitate with TR4-2-4A.
In order to determine whether TR4-2 could support the external and endogenous
genome protective functions of pol ζ, we tested both formation of micronuclei in
unchallenged cells, one marker of genomic instability, and cellular sensitivity to cisplatin.
Consistent with large scale genomic stress, ~15-23% of unchallenged Rev3l KO MEFs had
at least one micronucleus, relative to Rev3l HET MEFs which had a micronucleus frequency
of ~1-3% (Fig 7A). Stable TR4-2 expression in Rev3l KO MEFs restored micronucleus
frequency to near-normal, demonstrating that TR4-2 can restore some Rev3l genome
protective functions.
In order to test whether TR4-2 can rescue the roles of pol ζ in DNA damage
tolerance, we examined hypersensitivity to cisplatin. As expected, Rev3l KO + empty vector
MEFs were hypersensitive to cisplatin relative to the Rev3l HET MEFs + empty vector.
Stable expression of TR4-2 in Rev3l KO MEFs reversed the hypersensitivity to cisplatin (Fig
7B). This indicates that in this context TR4-2 can restore REV3L’s function in DNA damage
tolerance in response to cisplatin. When the TR4-2-4A was stably expressed, at similar
levels to TR4-2, it failed to reverse the hypersensitivity to cisplatin in Rev3l KO MEFs (Fig
7B). This indicates that the rescue of cisplatin sensitivity by TR4-2 is tied to pol ζ function.
However, we have yet to examine the impact of TR4-2-4A expression on micronuclei
formation in the Rev3l KO MEFs. Given that little is known about pol ζ function in responding
to endogenous sources of stress and/or damage, it would be of interest to determine
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whether the complete pol ζ complex with the REV7 dimer, POLD2, and POLD3 is required
for this action.
Furthermore, it would be of interest to determine how micronuclei arise in Rev3l KO
cells. Micronuclei could arise from fragmented chromosomes that missegregate or they can
arise from a whole chromosome missegregating. We hypothesize that the micronuclei are
arising from chromosome fragmentation because in primary cells loss of Rev3l leads to
chromatid and chromosome breaks [86].
In order to see if we observe an increase in markers consistent with constitutive DNA
breakage we stained cells with γ-H2AX, a phosphorylated form of the histone that marks
events of DNA damage and stress [135] and 53BP1, a protein involved in repairing DNA
double strand breaks [136]. While 53BP1 is a more specific indicator for double strand
breaks, 53BP1 can form nuclear bodies during other stress conditions [137]. We quantified
the number of 53BP1 foci per cell and did not see significant differences between the Rev3l
HET and KO cell controls although foci were readily detectable (Fig 8). This could be
ascribable to a high background for 53BP1 foci in our MEFs due to oncogenic stress arising
from T-antigen immortalization. In fact, stable T-antigen integration into cells has been
shown to induce 53BP1 foci [138].
A single chromosome break could result in the formation of a micronucleus, but a
high background of 53BP1 foci in our cells would obscure a low frequency of significant pol
ζ-dependent events. Future experiments could test the hypothesis that the micronuclei in
Rev3l KO arise from chromosome fragmentation. For example, we could stain for a
centromere marker, CENPA, to determine if the micronuclei arise from either a complete
chromosome or a fragment.
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Figure 6: Stable overexpression of a shortened Rev3l construct (TR4-2) in Rev3l knockout
MEFs. A) Schematic of full-length human REV3L and human REV3L construct, TR4-2. TR4-2
retains most conserved domains and binding sites of REV3L including the regions that coordinate
interactions with the accessory subunits of pol ζ, the C-terminal domain (CTD, purple) the two REV7
binding sites (R7B, black), and a positively charged domain (PCD) of uncertain function. The B-family
catalytic core is formed by folding of the N-terminal domain (NTD, green) and the polymerase domain
(POL, red) [139]. Mutation of the four essential prolines (4A) in the Rev7 binding sites results in
disruption of Rev7 binding. Mutation of two conserved aspartic acid residues in the POL domain
results in a predicted polymerase dead active site mutant (ASM). B & C) Immunoblot with HA
antibody showing stable expression of TR4-2 with an N-terminal Flag-HA tag in Rev3l KO MEF
clones. Clone ID numbers indicated above the lanes. D) 4A mutation disrupts REV7 binding to TR4-2.
TR4-2 constructs were transiently expressed in HEK293T cells. Cells were lysed and Flag-HA tagged
TR4-2 was immunoprecipitated with anti-FLAG (M2) agarose. Input and immunoprecipitated were
analyzed for REV7 and Flag (TR4-2) expression. Full immunoblots shown in the Appendix Fig 20 &
21.
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Figure 7: Overexpression of a shortened Rev3l construct (TR4-2) rescues phenotypes of pol ζ
loss, but no rescue occurs with a TR4-2 mutant that fails to bind REV7.
A) Stable expression of TR4-2 decreases micronuclei formation in unchallenged Rev3l KO MEF
clones. Clone ID numbers displayed on the x-axis. B) Stable expression of TR4-2 in Rev3l KO MEF
clones reverses hypersensitivity to cisplatin. MEFs were exposed to the indicated cisplatin
concentrations for 48 h and relative survival was quantified with the ATPlite assay. 3 replicates are
plotted; error bars represent standard deviation.
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Figure 8: Frequency of 53BP1 foci is not significantly altered in Rev3l HET and KO MEFs. Cells
were stained with γ-H2AX, 53BP1, and DAPI. A) Nuclear 53BP1 foci per cell were quantified using
the Imaris software. B) Example of cells with γ-H2AX and 53BP1 foci in Rev3l KO #15.
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2.2 Investigating the role of polymerase activity in the function of overexpressed
TR4-2
As described in Chapter 1, work with the active site mutant in mice shows that the
polymerase function of REV3L is essential for its in vivo activities. Mice homozygous for an
active site mutation (ASM) that substitutes two of the three highly conserved aspartic acid
residues in the active site with alanine die early in development, similar to homozygous
knockout mice [7, 95]. Additionally, MEFs with one null allele and one ASM allele
of Rev3l phenocopy homozygous Rev3l null mice MEFs, with respect to spontaneous
accumulation of DNA damage, rapid senescence, and hypersensitivity to cisplatin and UV
radiation [7]. Together this strongly indicates that the polymerase activity is necessary for pol
ζ function.
Surprisingly when TR4-2 ASM was stably expressed at comparable levels to TR4-2
(Fig 6C), this was sufficient to restore normal cisplatin sensitivity in two clones (Fig 9A).
Whether TR4-2 ASM expression is also sufficient to reduce accumulation of genomic
damage remains to be tested. Given that these clones with the ASM construct were more
difficult to isolate than any other construct used, one possible explanation is that alternative
mutations or aberrations conferring cisplatin resistance were selected in these ASM clones.
In order to determine whether this ability to rescue was dependent on the TR4-2 ASM and
not other mutations, I knocked down TR4-2 ASM and TR4-2 levels with shRNA (Fig 9B).
Knockdown of TR4-2 or TR4-2 ASM reduced the resistance to cisplatin treatment although
not to levels of the knockout control (Fig 9C). This suggests that the TR4-2 ASM does
promote a reduction in cisplatin sensitivity in Rev3l knockout MEFs. An alternative
hypothesis to explain the confounding result of the TR2-4 ASM, is that overexpression of the
TR4-2 construct results in novel functions that are not carried out by endogenous levels of

32

full length REV3L, where work in mice and primary MEFs has shown it is required for pol ζ
function [7].
TR4-2 levels in the MEF clones is very likely overexpressed compared to
endogenous Rev3l levels. This is based on two key observations described below, although
this hypothesis should be tested by comparing the mRNA levels in the future. Stable
expression of exogenous Rev3l cDNA, which is roughly comparable to endogenous levels,
is undetectable on the protein level [7]. Alternatively, TR4-2, which can be expressed at
much higher levels transiently [8], produces readily detectable protein levels (Fig 6B-C).
One hypothesis as to how overexpression of TR4-2 ASM could contribute to cisplatin
resistance is that TR4-2 ASM could be recruiting REV1 to sites of cisplatin lesions. REV1
could then mediate recruitment of other translesion DNA polymerases leading to damage
tolerance independent of pol ζ polymerase activity. If this hypothesis is true it would be
interesting to examine whether pol ζ promotes REV1 recruitment following DNA damage in
cells with endogenous levels of the full length REV3L.
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Figure 9: Overexpression of an active site mutant (ASM) TR4-2 confers reduced sensitivity to
cisplatin in Rev3l KO MEFs. A) Stable expression of TR4-2-ASM in Rev3l KO MEF clones fails to
reverse hypersensitivity to cisplatin. MEFs were exposed to the indicated cisplatin concentrations for
48 h and relative survival was quantified with the ATPlite assay. 5 replicates are plotted error bars
represent standard deviation. B) Levels of TR4-2 in Rev3l KO cells stably expressing shRNA either
non-target (shNT) or against Rev3l (shRev3l) were detected by HA immunoblot. Full immunoblots
shown in the Appendix Fig 22. C) Reduction of TR4-2 and TR4-2-ASM levels sensitizes cells to
cisplatin. MEFs were exposed to the indicated cisplatin concentrations for 48 h and relative survival
was quantified with the ATPlite assay. 2 replicates are plotted error bars represent standard
deviation. A higher end point concentration (10 μM) was used to determine more subtle changes.
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2.3 Investigating the consequences of cancer-associated REV3L mutants.
One consequence of the genome protective function is that pol ζ acts as a tumor
suppressor. In mouse models, our laboratory has found greatly increased incidence and
reduced latency of cancers when pol ζ is conditionally inactivated. But are there human
cancers that have lost pol ζ function? The significance of being able to identify cancers with
deficient pol ζ is that cells lacking functional pol ζ are exquisitely sensitive to the
chemotherapeutic agent, cisplatin (Fig 7). An understanding of pol ζ inactivating mutations
could aid in identifying patients who may respond better to treatment with platinum-based
chemotherapeutics.
Recently a REV3L mutation, R187W, was found in four family members who either
had colorectal cancer or other adenocarcinomas [140]. This study indicated that this
mutation is associated with loss of heterozygosity, and thus it is a candidate causative
mutation or linked to another causative mutation. This residue in the NTD is likely surfaceexposed based on structural prediction that uses the crystal structure of yeast pol δ, a fellow
B family polymerase, as a template (SWISS-MODEL). Therefore, I hypothesized that this
mutation may impact REV3L function either by causing a structural disruption or by
perturbing protein-protein interactions, although this mutation had no impact on Rev7
binding (Fig 6D). However, stable expression of expression of TR4-2-R187W, was able to
rescue the hypersensitivity to cisplatin in Rev3l KO MEFs (Fig 10 & 11C).
Using the cBioportal database [141, 142] we found numerous mutations in REV3L
as would be expected for gene that is over 10 kb. There were over eight hundred REV3L
mutations in the official curated set of nonredundant cancer studies that included over
47,000 patient samples, resulting in roughly 3% of cancer patient samples carrying
alterations in REV3L. These mutations included deep deletions, frame-shift and nonsense
mutations, and point mutations of unknown significance. Intriguingly primary prostate cancer
samples constitute the majority of the deep deletions, for example in the TCGA prostate
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adenocarcinoma cancer study ~8% of sample are annotated as having a deep deletion in
REV3L.
Whether nonsynonymous cancer-associated mutations impair the function of pol ζ is
unknown. We focused on highly conserved mutations in the polymerase domain, P2744S
and R2523C, that were predicted to be damaging based on structural and evolutionary
constraints (Poly-Phen-2 [143]). The P2744S mutation was found in a single colorectal
adenocarcinoma patient. A prostate cancer cell line, DU145, has the R2523C mutation.
Another reason these mutations were selected was that these patient genomes were scored
as having a shallow deletion in Rev3l, opening up the possibility that there could be a loss of
heterozygosity. Stable expression of TR4-2-P2744S and -R2523C were both able to rescue
the increased sensitivity to cisplatin in Rev3l KO MEF cells (Fig 10 &11A-B), indicating that
pol ζ is functional with these mutations under these experimental conditions.
However, given that at similar expression levels the TR-42-ASM mutant also was
able to restore cisplatin sensitivity to normal levels (Fig 6-7), it is possible that a phenotype
would not be detected even if any of these mutants impact the polymerase activity.
Therefore, it is still possible that these mutations may impact pol ζ function if expressed at
closer to endogenous levels.
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Figure 10: Stable overexpression of selected cancer-associated mutants in TR4-2 in Rev3l KO
MEFs. Immunoblots with HA antibody showing stable expression of TR4-2 and TR4-2 cancerassociated mutants with an N-terminal Flag-HA tag in Rev3l KO MEF clones. Clone ID numbers are
represented above each lane. Dotted line indicates same blot and exposure but additional samples
were cropped out. Membranes were cut to run HA (TR4-2) and tubulin immunoblotting from the same
membrane. For the tubulin blot shown at the bottom of C), the membrane was cut too close to tubulin
(full immunoblot in Appendix Fig 25). As a result, the left side of the tubulin blot has been partially cut
off. Full immunoblots are also in the Appendix for A) (Fig 23) and B) (Fig 24).

37

Figure 11: Overexpression of selected cancer-associated mutants in TR4-2 rescue cisplatin
hypersensitivity in Rev3l KO MEFs. Rev3l KO MEFs stably expressing TR4-2 or mutant TR4-2, A)
P2744S, B) R2523C, and C) R187W, were treated with cisplatin for 48 hours and sensitivity was
measured by ATPlite assay. 3 replicates are plotted. Error bars represent standard deviation.
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CHAPTER 3: Results & Discussion
Disruption of pol ζ induces an innate immune response

Parts of this chapter are adapted from a manuscript uploaded to bioRχiv. “Deficiency in
Translesion DNA Polymerase ζ Induces an Innate Immune Response” by Sara K. Martin,
Junya Tomida, and Richard Wood. doi: https://doi.org/10.1101/2020.03.02.972513

3.1 Loss of pol ζ triggers large scale transcriptional changes

In order to uncover the type of stress occurring in cells lacking pol ζ, we performed
genome-wide mRNA sequencing on a controlled set of immortalized clones: Rev3l
HET + empty vector, Rev3l KO + empty vector and Rev3l KO + TR4-2. To focus on
major changes, we set a strict threshold (> |2| log2 fold change and FDR < 0.05).
Expression analysis of 17,346 mapped transcripts revealed that 1117 transcripts
were either upregulated or downregulated in the Rev3l KO + empty vector relative to
the Rev3l HET + empty vector MEFs (Fig 12A). The majority (~68%) were
upregulated (Fig 12A). Gene ontology analysis was conducted by IPA on both
upregulated and downregulated genes that met the threshold > |2| log2 fold change
and FDR < 0.05. The differentially expressed genes displayed no statistically
significant enrichment or depletion for DNA replication or canonical DNA damage
sensing pathways. This is not completely unexpected given that p53 promotes much
of the transcriptional response to DNA damage and our MEFs have inactivated p53
due to large T-antigen immortalization. In these immortalized high passage cells, we
are likely to observe stable transcriptional alterations, rather than an acute response.
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Instead the upregulated genes displayed an enrichment in immune systemrelated pathways, as revealed by gene ontology analysis (Fig 12B). Upstream
regulator analysis was used to analyze all differentially expressed genes. Upstream
regulator analysis is a method that compares the overlap between differentially
expressed genes to those of known regulators, like transcription factors. Given the
direction of the expression of the overlapped genes it also predicts whether a data
set is consistent with the upregulator being activated or inactivated. This revealed
that the alterations in the transcriptome are consistent with activation of positive
regulators of the interferon response, including key transcription factors in this
pathway, IRF3 and IRF7 (Fig 12C). Importantly the predicted activation of IRF3 and
IRF7 was reversed by expression of the Rev3l TR4-2 cDNA, showing that these
results stem from a function of Rev3l. The same trends were also observed by
applying a substantially lower threshold (log2 FC > |0.5|) for differentially expressed
genes. This increased the dataset to 2071 differentially expressed transcripts.
Pathway analysis showed a negative correlation with predicted TRIM24 activation.
TRIM24 is an E3 ubiquitin ligase and also functions as a regulator of transcription.
TRIM24 suppresses interferon-stimulated gene expression [144], confirming that our
data is consistent with expression of interferon stimulated genes.
To explore whether our data set is in fact consistent with an interferon
response, we analyzed a curated set of 25 known interferon stimulated genes and
observed elevated expression in the Rev3l KO relative to the Rev3l HET MEFs,
which was partially reduced by TR4-2 stable expression (Fig 12D). These genes
were selected from papers that show an induction of an interferon response after
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endogenous sources of stress [123, 124]. Together our results reveal that disruption
of pol ζ promotes induction of interferon-stimulated genes.

Figure 12: Cells deficient in DNA polymerase ζ have an altered transcriptome.
A) Differentially expressed genes in Rev3l KO + empty vector relative to Rev3l HET + empty
vector using the threshold of a log2 fold change of > |2| and a false discovery rate of < 0.05.
B) Top 10 GO (Gene Ontology) terms reveal enrichment of immune system related genes in
upregulated genes in Rev3l KO MEFs. C) Upstream regulator analysis reveals the data set
is consistent with predicted activation of positive regulators of an interferon response in
Rev3l KO MEFs. D) Heatmap of a set of 25 known interferon-stimulated genes.
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3.2 Loss of pol ζ triggers increased expression of interferon-stimulated genes
RNA sequencing revealed large scale transcriptional changes due to loss of pol ζ function
that were consistent with activation of an interferon response. This significant transcriptional
trend was partially reduced upon stable expression of a REV3L construct, TR4-2. This was
important to show that our transcriptional changes were induced by loss of REV3L and not
due to genetic diversity generated by the genomic instability in Rev3l knockouts. However,
since our complemented cell lines were generated using lentivirus constructs and grown
continually under selection, I investigated these results in the parental Rev3l KO and Rev3l
HET MEF cell lines and one additional set of cell lines to limit extraneous variables.
I confirmed an increase in mRNA expression of specific interferon stimulated genes
in the Rev3l KO MEFs relative to the control cell lines (Fig 13). In order to extend these
findings to the protein level, we examined interferon stimulated gene products by
immunoblotting. Corresponding to an increase in mRNA levels, we also observed an
increase in protein levels of known interferon stimulated genes, MDA5 (encoded by the
IFIH1 gene), ISG15, and viperin (encoded by the RSAD2 gene) (Fig 14A). Additionally, we
observed an increased phosphorylation of a transcription factor IRF3 indicative of its
activation (Figure 14C). IRF3 is a key mediator in interferon signalling. Together these data
indicate that an interferon branch of the innate immune system may be activated due to
disruption of pol ζ function. Since it seems unlikely that pol ζ plays a direct role in
transcriptional regulation, the next obvious question is how and why loss of pol ζ induces the
expression of interferon stimulated genes.
The major consequence of pol ζ disruption in unchallenged mammalian cells is
increased genomic instability as evidenced by multiple markers including chromosome
fragmentation and aberrations, and micronuclei [7, 85, 86, 94]. Therefore, it seems likely
that this transcriptional response ultimately stems from the vast genomic damage induced
by loss of pol ζ function. Consistent with this hypothesis, the innate immune system not only
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can recognize and mount an interferon response to foreign DNA, but also can respond to
endogenous DNA that has escaped from the nucleus [145]. In some instances, this
response can halt cell growth causing organisms to shut down proliferation of virally infected
cells and cells with dangerously fragmented genomes [127, 146].
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Figure 13: Disruption of Rev3l results in increased expression of interferon-stimulated genes.
Gene expression (2-∆Ct) of selected interferon stimulated genes normalized to HPRT detected by
qRT-PCR. Error bars represent standard deviation. Unpaired student t-test, * = p < 0.05, ** = p < 0.01
and *** = p < 0.001.
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Figure 14: Disruption of Rev3l results in increased protein levels of interferon-stimulated
genes. A) Immunoblots showing increased protein levels of interferon stimulated genes, MDA5,
ISG15, and viperin. B) Immunoblot showing presence of components of the innate immune system,
cGAS and STING, in MEFs, with reduced STING in pol ζ knockout cells. C) Enhanced
phosphorylation of S888 of IRF3 (corresponding to S396 in humans) in Rev3l KO MEFs. Full blots
are shown in the Appendix Fig 26.
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3.3 The cGAS-STING pathway drives the interferon-stimulated gene signature in pol ζ
deficient cells
Mammalian cells have a host of cytosolic nucleic acid sensors that patrol the cytosol for
DNA. One of these, cGAS, is increasingly recognized to be of paramount importance in the
induction of an interferon response to both exogenous and endogenous cytosolic DNA
[145]. When cGAS binds to double stranded DNA, it activates its enzymatic activity and
results in the production of cGAMP, a cyclic dinucleotide. cGAMP binds to the STING
receptor on the membrane of the endoplasmic reticulum, resulting in activation of kinases
including TBK1 which can in turn phosphorylate and activate IRF3, a central transcription
factor in the interferon response.
Given that the cGAS-STING axis has been implicated specifically in responding to
endogenous DNA damage and has been correlated with micronuclei formation, we asked
whether cGAS-STING promotes the induction of expression of interferon stimulated genes
due to loss of function of pol ζ. Consistent with most MEFs having a functional innate
immune system [147], both Rev3l KO and HET MEF cell lines expressed both cGAS and
STING (Fig 14B). We noted a decrease in STING expression in Rev3l KO MEFs, which is
consistent with a constitutive activation of the cGAS-STING pathway, as cGAS activation
leads to a negative feedback loop resulting in STING degradation [148, 149].
This led us to investigate if cGAS-STING drives expression of interferon-stimulated
genes upon loss of pol ζ. Knockdown of either cGAS or STING significantly reduced the
mRNA expression of selected interferon stimulated genes (Fig 15A-B). Depletion of cGAS
or STING in Rev3l KO MEFs markedly reduced the protein levels of selected interferonstimulated genes and S888 phosphorylation of IRF3 (Fig 16). Together this indicates that
disruption of pol ζ function promotes activation of an innate immune response driven by the
cGAS-STING axis.
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Figure 15: The cGAS-STING pathway promotes expression of interferon stimulated genes due
to loss of pol ζ function. A) Knockdown of cGAS or STING reduces mRNA expression of CCL5,
CXCL11, RSAD2 (which encodes Viperin protein), IFIH1 (which encodes MDA5) as detected by qRTPCR in Rev3l KO 1. Gene expression (2-∆Ct) of selected interferon stimulated genes normalized to
HPRT detected by qRT-PCR. Error bars represent standard deviation. Unpaired student t-test, * = p <
0.05, ** = p < 0.01, *** = p < 0.001, and **** = p < 0.0001. B) Same as in A except with Rev3l KO 2.
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Figure 16: Knockdown of cGAS and STING reduces markers of an interferon response. A)
Efficient knockdown of cGAS or STING protein levels. B) MDA5, ISG15, and Viperin protein levels
decrease with cGAS and STING knockdown. C) Phosphorylation of S888 in mouse (analogous to the
human S396) of IRF3 in Rev3l KO MEFs decreases with knockdown of cGAS and STING. Equal
protein loading was monitored by REVERT total protein stain. Full blots are shown in the Appendix
Fig 26.
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Figure 17: Model for disruption of pol ζ triggering an innate immune response. Loss of pol ζ
induces genomic damage that results in accumulation of forms of cytosolic DNA, including
micronuclei at a minimum. This results in DNA binding of cGAS and activation of STING which
indirectly promotes phosphorylation and activation of IRF-3. This triggers the expression of interferon
stimulated genes (ISG).

49

3.4 Conclusions & Future Directions
Pol ζ stands apart from the other translesion polymerases in that it is required for
mammalian development and proliferation of primary cells. Now we can add that in addition
to activating p53-dependent responses, disruption of pol ζ function invokes a prominent
innate immune response promoted by the cGAS-STING pathway (Fig 17).
It is remarkable that disruption of an enzyme commonly thought of as a specialized
translesion synthesis polymerase can lead to a constitutive innate immune response.
Recently, cells with loss of function of key DNA repair enzymes, RNaseH2, BRCA2, and
BLM have been shown to have an elevated cGAS-STING response that correlates with an
increase in micronuclei that colocalize with cGAS [121, 124-126]. There are several sources
of DNA damage that may give rise to a sustained response including cytosolic mitochondrial
DNA [123] and cytosolic DNA arisen from stalled and processed replication forks [122]. DNA
stress may continually arise from likely collapse of DNA replication forks in the absence of
pol ζ, which could promote formation of micronuclei and also release small fragments of
DNA. Further, some nuclear genes including pol ζ control mitochondrial DNA integrity, and
there is evidence that mitochondrial function is compromised without pol ζ [150]. It remains
to be seen whether micronuclei are the primary source of interferon signalling in cells
lacking pol ζ, or whether they are more of an indicator of DNA degradation.

Limitations and Advantages of Experimental Design
Some experimental techniques used here might impact the innate immune response that is
observed. Our cell lines expressing our TR-2 and empty vector (EV) constructs were made
by infecting the cells with lentivirus, which could induce an innate immune response. Since
we used replication incompetent virus and cells were grown for multiple passages, by the
time of analysis it is unlikely that there was lentivirus present impacting our results. The
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TR4-2 expressing and EV control cell lines were derived from random DNA integration
mediated by the lentivirus, which could be a confounding variable. This is why I chose to
validate the results of increased expression of interferon-stimulated genes in the parental
cell lines that had not been infected with lentivirus.
Additionally, all our cell lines were generated using adenovirus expressing the Cre
recombinase and adenovirus can induce a transient cGAS-STING response [151]. We are
using high passage cell lines and are unlikely to have remaining effects. However, this is the
reason why we use Rev3l HETs (Rev3l+/∆) as our control because they have gone through
the same adenovirus infection and Cre-induced recombination as our Rev3l KOs (Rev3l-/∆)
so that we have a control for unexpected impacts of the technique. But, if we do follow up
studies in primary MEFs where we are monitoring the cells shortly after adenovirus-Cre
infection we would need to carefully control for this with a mock infection and infection with
an empty adenovirus without Cre.
While using cell lines immortalized with large T-antigen, made our experiments
feasible, it could impact the results. Large T-antigen binds to and inhibits p53 and p53 and
the interferon response influence each other [152-160]. However, we see a dramatic
increase in interferon-stimulated genes from our control cells relative to the Rev3l KO MEFs.
In fact, the presence of large T-antigen may be muting the innate immune response we see,
give that large T-antigen supresses the interferon response to DNA in primary MEFs [161].
As discussed below, follow up experiments in primary MEFs could help answer this
question.

Does activation of the cGAS-STING pathway contribute to the toxicity of pol ζ loss?
An interferon response can result in suppressing cell growth. Specifically, cGAS has been
tied to promoting senescence in primary cells [127, 146]. Our experiments were performed
in large T-antigen immortalized MEFs. In addition to blunting p53 activity, large T-antigen
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has been implicated in impairing an interferon response to nucleic acids [161]. Loss of pol ζ
would likely induce an innate immune response of even greater magnitude in primary MEFs.
Primary MEFs lacking pol ζ only survive approximately two cell divisions before cell growth
completely halts, which is accompanied by an increase in senescent cells [86]. An essential
function of pol ζ is also evident from the failure of Rev3l-defective embryos to develop, and
from the inability of Rev3l-defective primary keratinocytes to proliferate in a mouse model
[86, 94, 139]. It is possible that cGAS-STING drives this severe growth arrest in primary
cells due to loss of pol ζ function. In order to test this, we could cross our Rev3l
heterozygous (- /flox) mice against a cGAS knockout. First, this would help us answer if
removing the cGAS-STING pathway can delay or reverse embryonic lethality in mice caused
by Rev3l disruption. Second, we could then redrive our ex vivo knockout primary MEF
system and determine the cell proliferation, senescence, and expression of interferonstimulated genes following Rev3l deletion in cGAS deficient cells (Rev3l-/∆cGAS-/-) versus
cGAS proficient cells (Rev3l-/∆cGAS+/+). It would be important to also compare to the Rev3l+/∆
in both cGAS wildtype and knockout backgrounds.

Are there other forms of immunostimulatory DNA due to Rev3l disruption?
While we have shown that micronuclei accumulate with loss of pol ζ, it remains to be seen if
this is the sole actor that ignites the innate immune response. While proving a causal
relationship would be exceedingly difficult if not impossible. It would be more straightforward
to explore whether loss of pol ζ leads to the accumulation of other immunostimulatory
nucleic acids.
Nucleic acids in the cytosol can arise from multiple sources. One generic way to test
for their presence, is by looking at their localization and intensity using immunocytochemistry
with antibodies raised against, double stranded DNA, single stranded DNA or double
stranded RNA. Given that all of these have been shown to correlated with activation of an
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innate immune response and can trigger it through different receptors, it would be worth
looking at whether additional pathways contribute to the innate immune response in addition
to cGAS-STING pathway.
For example, single stranded DNA (ssDNA) has been shown to accumulate in the
cytosol in cell under replicative stress [122]. We set out to test whether Rev3l KO MEFs do
or do not have increased ssDNA in the cytosol. We used a ssDNA antibody that has been
used to detect ssDNA in the cytosol previously with immunofluorescence [162]. However,
we were unable to detect specific staining between the Rev3l KO and the HETs (Fig 18).
For a positive control we knocked down TREX1, a ssDNA scavenger, in the Rev3l
HET MEFs (Fig 19). TREX1 acts to reduce accumulation of ssDNA in the cytosol by acting
as a nuclease to degrade the endogenous ssDNA in the cytosol. Deletion of TREX1 induces
cytosolic ssDNA accumulation and activates the cGAS-STING pathway [162, 163].
However, depleting TREX1 levels, failed to induce any clear changes in ssDNA staining (Fig
18 & 19). Given that our positive control did not show elevated ssDNA levels, we do not
know if the experimental conditions are suitable for ssDNA detection or if our TREX1
knockdown was insufficient to induce ssDNA accumulation. As a result, we are not able to
make a conclusion one way or the other whether loss of pol ζ results in the accumulation of
ssDNA.

53

Figure 18: Staining Rev3l KO MEFs with a ssDNA specific antibody. Cells were stained with a
ssDNA specific antibody (red) and DAPI (blue).
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Figure 19: Knockdown of TREX1 in Rev3l HET 1. Cells were transfected either 30 or 10 nM of
either CTL or a pool of three TREX1 siRNAs. Total protein loading was monitored by REVERT total
protein stain left and TREX1 levels were assessed with a TREX1 antibody right 48 hours after siRNA
transfection. For the staining in figure 18, 30 nM concentrations were used.
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Is the innate immune response primarily driven by cGAS-STING or do other innate immune
pathways contribute?
In particular, it would be intriguing to ask whether there are altered levels of RNA in the
cytosol. Viral RNA and self RNA, under certain (often pathogenic) circumstances, can trigger
an innate immune response through binding cytosolic RNA sensor [164]. One key receptor
is MDA5, which has elevated levels dependent on cGAS-STING pathway, in the Rev3l KO
MEFs (Fig 15A). If disruption of pol ζ is inducing elevated levels of RNA in the cytosol, it
could contribute to the transcription of ISGs. And since elevated MDA5 levels are cGASSTING dependent, knockdown of cGAS-STING could partially be working through
suppression of RNA sensing. This could be followed up by knocking down various RNA
sensors, including MDA5 and Rig-I, and monitoring whether this impacts the expression of
interferon-stimulated genes. However, if Rev3l null MEFs don’t have increased levels of
RNA in the cytosol it would indicate that the activation of the innate immune response is
primarily tied to cytosolic DNA sensing.

What is the function of pol ζ in unchallenged cells?
The activation of the cGAS-STING pathway now provides us with a tool to probe how pol ζ
prevents accumulation of genomic damage. For instance, in yeast it has been suggested
that pol ζ bypasses incorporated ribonucleotides (rNMP). By overexpressing the RNaseH2
complex, which repairs incorporated ribonucleotides, we could determine whether reduction
of the load of rNMPs in the genome alleviates the activation of the cGAS-STING pathway in
Rev3l KO MEFs. We obtained a vector overexpressing RNase H2 complex (RNase H2 A, B
and C) from Dr. Andrew Jackson’s lab (unpublished). Pilot studies of this experiment have
been technically challenging due to the fact the transfection appears to be toxic to the Rev3l
KO MEFs (data not shown, more work needed). This would be consistent with the fact that
plasmid DNA could activate the innate immune system. The constitutive activation of the
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cGAS-STING pathway could be priming the innate immune response in the Rev3l KO
MEFs.

Can targeted disruption of the pol ζ complex induce activation of the cGAS-STING pathway?
In addition to widening our understanding of the importance of the genome protective
functions of pol ζ, these results could have an impact on translational approaches. A
potential approach, suggested by experiments in laboratory settings, has been to disrupt pol
ζ function to enhance chemotherapeutic effectiveness [103, 105, 165]. For example, an
inhibitor that impairs the interaction of pol ζ with the master regulator REV1 has been
developed that sensitizes cancer cells and xenograft tumors to cisplatin treatment [39]. Our
work suggests that such inhibitors might also induce an interferon response. This approach
would have multiple advantages for therapy by enhancing DNA damage sensitivity, limiting
induced mutations, and potentially enhancing a cytotoxic immune response in targeted cells.
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CHAPTER 5: Materials and Methods

Cell Lines
The immortalized Rev3l knockout (KO) and heterozygous (HET) mouse embryonic fibroblast
(MEF) parental cell lines in this study were as described [86]. In brief, the Rev3l KO MEFs
were generated by T-antigen immortalization of primary MEFs isolated from mouse embryos
with one null Rev3l and one floxed allele, followed by ex vivo Ad-Cre deletion of the floxed
allele, and clonal selection to ensure a homogenous population with the genotype Rev3l-/∆.
The Rev3l HET MEFs were isolated in the same manner expect starting MEFs from
embryos with one wild-type and one floxed allele, resulting in MEFs with the genotype
Rev3l+/∆. The floxed allele was generated by placing loxP sites flanking two conserved
exons, corresponding to residues 2776-2860, that contain the three conserved catalytic
aspartate residues of REV3L [90]. The null allele replaced these two exons with a lacZ-neoR
cassette [89]. In this study two sets of clones were analyzed. Cells were grown in DMEM
(Sigma #5796), 10% Fetal Bovine Serum (FBS) and 1 X penicillin/streptomycin (Gibco
#15140122).

Generation of TR4-2 expressing Rev3l KO MEFs
The TR4-2 construct, a gift from Dr. Wei Yang [8], was cloned into the pCDH backbone with
an N-terminal Flag-HA tag as the same previously described for the full length Rev3l cDNA
[16]. The pCDH-Flag-HA-TR4-2 or pCDH-Flag-HA empty vector was stably inserted into the
MEF cell lines using lentiviral infection as previously described [7]. Three single clones were
isolated for analysis and continually grown in 1 μg/mL of puromycin to ensure stable
integration of the construct.
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Stable knockdown of TR4-2 construct using shRNA
The SMARTvector Lentiviral mEF1a-TurboRFP shRNA expressing shRNA targeted at fulllength human REV3L (Horizon, previously Dharmacon, #V3SH11240-225971878, target
mature mRNA: AGCGGAGCCATAATGAATA) or non-targeting shRNA (Horizon
#VSC11717) was integrated using lentiviral infection as above. Selection for shRNA positive
cells was achieved by sorting cells that expressed RFP using flow cytometry.

RNA isolation
RNA was isolated from 1.5 x 106 (Fig 2, RNA seq) 2.5 x 105 cells (Fig 3, gene expression) or
1 x 106 cells (Fig 4, gene expression), using the RNeasy Kit (Qiagen # 74104) following the
manufacturer’s instructions including the on-column DNase I digestion (Qiagen #79254).

Genome-wide mRNA sequencing
Library preparation and sequencing
mRNA libraries were prepared using the Illumina TruSeq Stranded mRNA kit following
manufacturer’s instructions and 2 x 75 base paired end sequencing was run on the Illumina
HiSeq 3000.
Sequence mapping and identifying differentially expressed genes
GENCODE Release M19 [2] using htseq-count from HTSeq package (version 0.6.0) [3] was
used to determine the number of fragments in identified genes. If genes had less than 10
fragments in all the samples, they were excluded from differential expression analysis.
R/Bioconductor package edgeR (version 3.8.6) [4] was used to statistically assess
differentially expressed genes. Genes with FDR (false discovery rate) ≤ 0.05, fold change ≥
|0.5| and length > 200bp were called as differentially expressed. More stringent cut-offs for
fold change were used for various analyses as described below.
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Analysis of differentially expressed genes
For gene ontology analysis, genes upregulated more than 4-fold with an FDR < 0.05 were
entered into DAVID 6.8 on 02/22/20 and the top 10 GOTERMS_BP_Direct were plotted
based on -log(p value) [166, 167]. For upstream regulator analysis, differential expressed
gene both upregulated and downregulated more than 4-fold with an FDR < 0.05. were
entered into IPA IPA (QIAGEN Inc.,
https://www.qiagenbioinformatics.com/products/ingenuity- pathway-analysis). Given that
upregulated genes are overrepresented in the Rev3l KO differentially expressed genes, this
results in an expected bias for upstream regulators that also predominately result in the
upregulation of targeted genes which we see in our data set. Since, bias-corrected z-scores
are not reported for upstream regulators with a |bias term| > 0.5, we’ve reported the
uncorrected z-score here. Given that the majority of differentially expressed genes are
upregulated in our dataset, bias is to be expected for transcription regulators that primarily
induce expression of genes.

Gene expression analysis
High Capacity cDNA Reverse Transcription (Applied Biosciences #4368814) was used to
prepare cDNA from 1000 ng of total RNA from each sample. qPCR was run iTaq Universal
SYBR Green Supermix (Biorad #1725121) on the Applied Biosystems 7900HT Fast RealTime PCR System. Gene expression of calculated using the 2-∆Ct method normalizing to the
HRPT gene. The following primers (5’ to 3’) were used for the mouse target genes:
HRPT forward: CTGGTGAAAAGGACCTCTCG
HRPT reverse: CAAGGGCATATCCAACAACA
CCL5 forward: ACGTCAAGGAGTATTTCTACAC
CCL5 reverse: GATGTATTCTTGAACCCACT
CXCL11 forward: AGGAAGGTCACAGCCATAGC
60

CXCL11 reverse: CGATCTCTGCCATTTTGACG
RSAD2 forward: ATAGTGAGCAATGGCAGCCT
RSAD2 reverse: AACCTGCTCATCGAAGCTGT
IFIH1 forward: CGGAAGTTGGAGTCAAAGC
IFIH1 reverse: TTTGTTCAGTCTGAGTCATGG
ISG15 forward: CTAGAGCTAGAGCCTGCAG
ISG15 reverse: AGTTAGTCACGGACACCAG
IRF7 forward: CAATTCAGGGGATCCAGTTG
IRF7 reverse: AGCATTGCTGAGGCTCACTT

Immunoblotting
Cell were lysed (3 million cells /100 μL) in lysis buffer (Tris-HCl: 50 mM, pH 7.5, NaCl
250 mM, EDTA 1 mM, Triton X-100 0.1%, 1 X Protease/Phosphatase Inhibitor Cocktail CST
#5872) for 30 min on ice with mixing every 10 min. Debris was pelleted by centrifugation at
15,000 x g for 20 min at 4˚C. Protein amounts were quantified using Biorad Protein Assay
(Biorad #500-0006) and a bovine serum albumin standard curve (Biorad #500-0007)
following manufacturer’s instructions. The samples were denatured using 4 x loading buffer
(LI-COR #928-40004). 25 μg of protein / well and Precision Plus Protein All Blue Standards
(Biorad #161-0373) were run on 4-20% polyacrylamide gels (Biorad #4561096) in 1 x
Tris/Glycine/SDS buffer (Biorad #161-0772). Protein was transferred to Immobilon-FL PVDF
Membrane (Millipore #IPFL00010) in 1 x Tris/Glycine buffer (Biorad #161-0772) 20%
methanol. After transfer, membranes were dried. Total protein was measured using
REVERT total protein stain kit (LI-COR #926-11010) following the manufacturer’s
instructions. Membranes were blocked for 1 h in 0.5X Odyssey Blocking Buffer (OBB, LICOR # 927-50000) in Tris Buffered Saline (TBS) and then incubated in primary antibody
overnight at 4˚C. The primary antibodies were used at the following dilutions in
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0.5XOBB/TBS/0.2% Tween-20. Rabbit anti-HA-Tag (C29F4) (CST #3724, 1:1000), Rabbit
anti-cGAS (Mouse specific) (D3O8O) (CST #31659, 1:1000), rabbit anti-STING (D2P2F)
(CST # 13647, 1:1000), rabbit anti-MDA-5 (D74E4) (CST # 5321, 1:1000), rabbit anti-ISG15
(CST # 2743, 1:500), rabbit anti-Phospho-IRF-3 (Ser396) (4D4G) (CST #4947, 1:1000),
rabbit anti-IRF-3 (D83B9) (CST #4302, 1:1000), mouse anti-viperin (Millipore #MAB106,
1:250), rabbit anti-STAT1 (D1K9Y) (CST: #14994, 1:1,000), rabbit anti-TBK1 (D1B4) (CST:
#3504, 1:1,000), and rabbit anti-Phospho-TBK1 (S172) (D52C2) (CST: #5483, 1:1,000).
After primary incubation membranes were washed three times in TBS/0.1% Tween20, and incubated for 1 h in secondary antibody either goat anti-Rabbit 800CW (LI-COR
#926-32211) or goat anti-mouse 800CW (Licor 827-08364) diluted 1:20,000 in 0.5X OBB
/TBS /0.2% Tween-20/0.01% SDS. After primary incubation membranes were washed three
times in TBS/0.1% Tween-20, rinsed with TBS, then dried and imaged on the LI-COR
Odyssey FC.
Sample preparation differed in Fig 10 as follows. Cells were lysed in 0.5 B lysis
buffer (500 mM KCl, 20 mM Tris–HCl [pH 8.0], 5 mM MgCl2, 10% glycerol, 1 mM PMSF,
0.1% Tween-20, 10 mM 2-mercaptoethanol). After sonication (1% Amp, 9 times: (5 sec:
pulse on, 15 sec: pulse off )) and centrifugation, lysates were denatured with concentrated
SDS buffer to yield a final concentration of 50 mM Tris–HCl [pH 6.8], 2% SDS, 0.1%
bromophenol blue, 10% glycerol, 100 mM dithiothreitol (DTT). In Fig 6D, the
immunoprecipitation of the FLAG tagged pCDH-FH-TR4-2 constructs overexpressed in
HEK293T cells using M2-Flag resin (Sigma #A2220) was carried out as described
previously [16].
The western blot procedure was the same with the following expectations for Fig 6D
and Fig 10. Blots were blocked with 5% milk / TBS-T for one hour at room temperature. The
primary antibody conditions are as follows mouse anti-FLAG: (Sigma #F3165), 1:10,000 in
TBS-T 4˚C overnight; rabbit anti-HA (CST #: 3724) 1:1,000 in 5% milk / TBS-T 4˚C
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overnight; and mouse anti-Tubulin (Sigma # T5168) 1:20,000 in TBS-T 20 minutes at room
temperature. Secondary antibodies were incubated for one hour at room-temperature
diluted to 1:10,000 in 5% milk / TBS-T. Secondary antibodies are as follows: HRPconjugated anti-mouse IgG (Sigma #A0168) and HRP-conjugated anti-rabbit IgG (Sigma #
A0545). Secondary antibodies were detected using Pierce ECL (Thermo) and film exposure
for Fig 6D and Fig10A-B and the Li-Cor Odyssey FC on the chemiluminescence channel for
Fig 10C.

Knockdown of cGAS and STING protein levels
600,000 cells were seeded in 10 cm plates. The next day, cells were transfected with 1 nM
of the appropriated siRNA using Lipofectamine RNAiMAX (ThermoFisher #13778150)
following the manufacturer’s protocols. The following dicer-substrate short interfering RNAs
were used: siCTL (IDT: Negative Control DsiRNA # 51-01-14-03), sicGAS (IDT: DsiRNA
Duplex mm.Ri.Mb21d1.13.1), and siSTING (IDT: DsiRNA Duplex mmRi.Tmem173.13.2).
After 48 h, cells were harvested in paired pellets for RNA and protein analysis and flash
frozen in liquid nitrogen.

Cisplatin sensitivity
10,000 cells were seeded in triplicate in 96 well plates. The following day cells were treated
with the appropriate concentration of cisplatin or vehicle control. After 48 h, the relative
survival of the cells was calculated by using the ATPlite assay (Perkin Elmer #606016943)
following the manufacturer’s instructions.
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Micronuclei frequency
20,000 cells per chamber were seeded on four-chamber slides. After 48 h, cells were fixed
in 100% methanol and slides were stained with DAPI. The slides were mounted and
imaged. Micronuclei were counted as discrete units distinct from the nucleus.

53BP1 and γ-H2AX foci confocal imaging
Cells were plated on collagen (PureCol Advanced Biomatrix, #5005B) coated coverslips and
let adhere and grow overnight. The cells were fixed in 4% PFA / 1% sucrose for 15 min at RT,
washed with PBS. Cells were permeabilized with 0.5% Triton X-100 for 10 min at room
temperature and block in Background Sniper (Biocare Medical, #BS966) for 15 min at

room temperature. Cells were incubated in primary antibodies for 2 hours at room
temperature. Primary antibodies were Rabbit anti-53BP1 (1:500, Bethyl Labs #A300-272A)
and Mouse anti-γ-H2AX (1:300, Millipore Sigma JBW301 #05-636-I). Cells were washed with
PBS and incubated with secondary antibodies for 1 h 35 min at room temperature. Secondary
antibodies were AlexaFluor 568 anti-mouse and AlexaFluor-647 anti-rabbit diluted 1:1,000.
Slides were imaged and foci were quantified using the Imaris software. Slides were washed,
stained with DAPI, mounted with Prolong Gold antifade (Invitrogen #9071) and imaged.
Nuclear foci were quantified using the Imaris software.

ssDNA staining
20,000 cells per chamber were seeded on four-chamber slides. After 48 h, cells were fixed
in 100% methanol. Slides were washed with PBS and incubated overnight in IgM antissDNA (MAB3299) diluted 1:20 in 5% Goat Serum in PBS. Slides were washed with PBS
and incubated for 1 h at room temperature with Goat anti-Mouse IgM Alexa Fluor 594
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(Thermo #A-21044) diluted 1:400 in 5% Goat Serum in PBS. Slides were washed, stained
with DAPI, mounted with Prolong Gold antifade (Invitrogen #9071) and imaged.

Statistics
Unpaired student t-tests were run on qPCR and micronuclei frequency results using Prism 8.
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APPENDIX: Full Immunoblots

Figure 20: Full immunoblots for Figure 7B & C. REVERT Total Protein Stain was used as
a loading control for each membrane. Dotted box indicates approximate region shown in
figure 7.
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Figure 21: Full immunoblots for Figure 7D. Tubulin Protein Stain was used as a loading
control for each membrane. Dotted box indicates approximate region shown in Fig 7D.
Image was converted to grayscale for Fig 7D.
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Figure 22: Full immunoblots for Figure 10B. C-15 = Rev3l KO + EV #15, T-21 = Rev3l
KO + TR4-2 #21, T(ASM)-71 = Rev3l KO + TR4-2-ASM #71. Green (left) is anti-HA (TR4-2)
and red (right) is the REVERT total protein as a loading control.
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Figure 23: Full immunoblots for Figure 11A. C-15 = Rev3l KO + EV #15, T-21 = Rev3l
KO + TR4-2 #21, T(ASM)-71 = Rev3l KO + TR4-2-ASM #71. Green (left) is anti-HA (TR4-2)
and red (right) is the REVERT total protein as a loading control.
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Figure 24: Full immunoblots for Figure 11B.

71

Figure 25: Full immunoblots for Figure 11C.
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Figure 26: Full immunoblots for Figure 15. Three independent experiments were run on
the same gels. Replicate B is shown in figure 3 as indicated by the white boxes. REVERT
Total Protein Stain was used as a loading control for each membrane. TBK1, phosph-172TBK1, and STING were also probed.
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Figure 27: Full immunoblots for Figure 17. Two independent experiments were run on the
same gels. Replicate B is shown in figure 4 as indicated by the white boxes. REVERT Total
Protein Stain was used as a loading control for each membrane. TBK1, phosph-172-TBK1,
and STING were also probed.
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